Ghana COVID-19 Emergency Preparedness and Response Project

Abstract*

The development objective of the COVID-19 (Coronavirus) Emergency Preparedness and Response Project for Ghana is to prevent, detect, and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Ghana. The project comprises of four components. The first component, emergency COVID-19 response consists of following sub-components: (i) case detection, confirmation, contact tracing, recording, and reporting;... Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Ghana

Key Details

Project Details

Project ID
P173788
Status
Active
Team Leader
Dorothee Chen
Borrower 2
Republic of Ghana

Country
Ghana
Disclosure Date
March 24, 2020
Approval Date
(as of board presentation)
April 2, 2020
Effective Date
April 3, 2020

Total Project Cost 1
US$ 365.00 million
Implementing Agency
Ministry of Health,Ghana Health Services
Region
Western and Central Africa
Fiscal Year 3
2020

Commitment Amount
US$ 365.00 million
Environmental Category
N/A
Environmental and Social Risk
Substantial
Closing Date
June 16, 2025

Consultant Services required
No
Last Stage Reached
BANK APPROVED
Last Update Date
May 23, 2024

Associated Projects
P178054
P176485
P174839

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Health Systems and Policies100%
- FY17 - Health Finance10%
- FY17 - Health Service Delivery64%
- FY17 - Health System Strengthening98%
- FY17 - Private Sector Delivery in Health17%

FY17 - Social Development and Protection

FY17 - Social Protection10%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Credit	365.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	365.00
IBRD + IDA Commitment	365.00

Lending Instrument
Grant Amount	N/A
Total Project Cost**	365.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Apr 2, 2020	IDA-66020	Loan Commitment	35,000,000.00
Nov 10, 2020	IDA-67950	Loan Commitment	130,000,000.00
Apr 29, 2022	IDA-71250	Loan Commitment	60,600,000.00
Jun 10, 2021	IDA-69230	Loan Commitment	200,000,000.00
Mar 13, 2024	IDA-69230	Loan Disb	339,482.70
Jun 3, 2024	IDA-71250	Loan Disb	350,779.38
May 16, 2024	IDA-71250	Loan Disb	1,554,011.20
May 16, 2024	IDA-71250	Loan Disb	130,984.64
Jun 24, 2024	IDA-71250	Loan Disb	388,471.25
Jun 14, 2024	IDA-69230	Loan Disb	-5,661,588.50
May 14, 2024	IDA-71250	Loan Disb	678,670.50
Jun 12, 2024	IDA-69230	Int Charges	1,419,531.40
Jun 12, 2024	IDA-69230	Int Charges	1,149,120.50
May 16, 2024	IDA-71250	Loan Disb	440,730.40
Jun 20, 2024	IDA-71250	Loan Disb	453,341.70
Jun 20, 2024	IDA-71250	Loan Disb	970,067.50
May 14, 2024	IDA-71250	Loan Disb	135,356.86
May 29, 2024	IDA-71250	Loan Disb	135,356.86
May 29, 2024	IDA-71250	Loan Disb	276,700.78
Jun 12, 2024	IDA-69230	Int Charges	1,419,531.40
May 29, 2024	IDA-71250	Loan Disb	106,070.20
May 23, 2024	IDA-71250	Loan Disb	2,134,000.00
Aug 16, 2024	IDA-67950	Int Charges	807,478.60
Aug 16, 2024	IDA-67950	Int Charges	807,478.60
Aug 16, 2024	IDA-67950	Int Charges	832,712.30
May 23, 2024	IDA-71250	Loan Disb	15,000,000.00
Aug 1, 2024	IDA-66020	Int Charges	855.37
Aug 1, 2024	IDA-66020	Int Charges	855.37
Jul 19, 2024	IDA-71250	Loan Disb	1,863,450.00
Jul 15, 2024	IDA-71250	Loan Disb	3,036,627.80
Aug 9, 2024	IDA-71250	Loan Disb	218,250.00
Aug 30, 2024	IDA-71250	Loan Disb	727,683.56
Aug 9, 2024	IDA-71250	Loan Disb	1,842,999.90
Apr 15, 2024	IDA-69230	Loan Disb	25,153.72
Feb 21, 2024	IDA-67950	Int Charges	22,410.29
Feb 21, 2024	IDA-67950	Int Charges	799,049.90
Feb 21, 2024	IDA-67950	Int Charges	799,049.90
Jul 3, 2024	IDA-69230	Loan Disb	-3,484,109.20
Feb 1, 2024	IDA-66020	Int Charges	124,310.24
Feb 1, 2024	IDA-66020	Int Charges	124,310.24
Feb 1, 2024	IDA-66020	Int Charges	211,446.44
Feb 1, 2024	IDA-66020	Int Charges	2,557.64
Feb 1, 2024	IDA-66020	Int Charges	2,557.64
Apr 22, 2024	IDA-67950	Loan Disb	2,097,870.80
Jun 26, 2024	IDA-71250	Loan Disb	1,117,450.40
Apr 25, 2024	IDA-71250	Loan Disb	703,986.70
Jun 26, 2024	IDA-71250	Loan Disb	284,316.88
Feb 21, 2024	IDA-67950	Int Charges	824,020.20
Sep 7, 2023	IDA-66020	Int Charges	210,047.81
Sep 7, 2023	IDA-66020	Int Charges	6,008.69
Sep 7, 2023	IDA-66020	Int Charges	126,028.71
Sep 7, 2023	IDA-66020	Int Charges	126,028.71
Jun 27, 2023	IDA-67950	Loan Disb	6,464,504.00
Aug 19, 2022	IDA-67950	Loan Disb	217,365.94
Aug 10, 2022	IDA-67950	Loan Disb	184,212.53
Jun 22, 2022	IDA-67950	Loan Disb	286,155.03
Jun 6, 2022	IDA-67950	Loan Disb	3,211,434.00
Mar 18, 2022	IDA-67950	Int Charges	486,704.78
Mar 18, 2022	IDA-67950	Int Charges	486,704.78
Mar 18, 2022	IDA-67950	Int Charges	501,914.28
Feb 1, 2022	IDA-66020	Int Charges	5,052.14
Feb 1, 2022	IDA-66020	Int Charges	5,052.14
Aug 10, 2022	IDA-67950	Loan Disb	110,647.27
Aug 1, 2022	IDA-66020	Int Charges	3,870.36
Aug 1, 2022	IDA-66020	Int Charges	3,870.36
Aug 25, 2022	IDA-67950	Loan Disb	183,498.19
Jan 6, 2022	IDA-69230	Loan Disb	1,437,036.00
Aug 9, 2022	IDA-67950	Loan Disb	288,273.66
Oct 17, 2022	IDA-67950	Loan Disb	1,343,000.00
Sep 6, 2022	IDA-67950	Loan Disb	303,427.38
Dec 21, 2021	IDA-69230	Loan Disb	5,511,240.00
Dec 17, 2021	IDA-69230	Loan Disb	3,856,646.80
Jan 3, 2023	IDA-67950	Loan Disb	362,020.72
Jan 3, 2023	IDA-67950	Loan Disb	299,498.66
Jan 3, 2023	IDA-67950	Loan Disb	147,721.77
Jan 3, 2023	IDA-67950	Loan Disb	421,992.56
Dec 20, 2022	IDA-67950	Loan Disb	218,250.00
Aug 24, 2022	IDA-67950	Loan Disb	406,289.16
Jan 12, 2022	IDA-69230	Loan Disb	18,825,916.00
Nov 9, 2022	IDA-67950	Loan Disb	383,305.00
Nov 9, 2022	IDA-67950	Loan Disb	160,917.69
Nov 28, 2022	IDA-67950	Loan Disb	406,098.60
Oct 19, 2022	IDA-67950	Loan Disb	131,092.94
Sep 7, 2022	IDA-66020	Int Charges	115,320.61
Sep 7, 2022	IDA-66020	Int Charges	115,320.61
Sep 7, 2022	IDA-66020	Int Charges	198,486.70
Dec 28, 2022	IDA-67950	Loan Disb	2,614,162.80
Dec 14, 2022	IDA-69230	Int Charges	987,251.40
Dec 14, 2022	IDA-69230	Int Charges	987,251.40
Dec 14, 2022	IDA-69230	Int Charges	807,223.10
Nov 19, 2021	IDA-69230	Loan Disb	19,840,464.00
Mar 18, 2022	IDA-69230	Loan Disb	6,000,000.00
Apr 26, 2022	IDA-67950	Loan Disb	986,000.00
Jan 5, 2024	IDA-69230	Loan Disb	2,465,000.00
Jan 5, 2024	IDA-69230	Loan Disb	3,685,959.50
Jan 5, 2024	IDA-69230	Loan Disb	442,258.38
Apr 9, 2024	IDA-69230	Loan Disb	193,997.88
Apr 11, 2024	IDA-69230	Loan Disb	3,731,918.20
Sep 15, 2023	IDA-67950	Int Charges	768,709.75
Sep 15, 2023	IDA-67950	Int Charges	768,709.75
Sep 15, 2023	IDA-67950	Int Charges	28,144.73
May 9, 2023	IDA-66020	Loan Cancel	56,370.36
Sep 15, 2023	IDA-67950	Int Charges	770,321.70
Dec 6, 2023	IDA-69230	Loan Disb	567,450.00
Nov 30, 2023	IDA-69230	Int Charges	1,324,461.00
Nov 30, 2023	IDA-69230	Int Charges	1,324,461.00
Nov 30, 2023	IDA-69230	Int Charges	1,082,941.60
Jun 1, 2023	IDA-69230	Int Charges	1,206,635.50
Jun 1, 2023	IDA-69230	Int Charges	1,206,635.50
Jun 1, 2023	IDA-69230	Int Charges	986,601.94
Dec 12, 2023	IDA-69230	Loan Disb	741,532.00
Dec 26, 2023	IDA-69230	Loan Disb	268,884.03
Jan 10, 2023	IDA-67950	Loan Disb	5,747,552.00
Sep 14, 2022	IDA-67950	Loan Disb	114,558.08
Sep 14, 2022	IDA-67950	Loan Disb	648,664.00
Nov 2, 2022	IDA-67950	Loan Disb	540,473.70
Nov 2, 2022	IDA-67950	Loan Disb	156,232.36
Jan 27, 2023	IDA-69230	Loan Disb	26,624,014.00
Feb 1, 2023	IDA-66020	Int Charges	12,529.26
Feb 1, 2023	IDA-66020	Int Charges	12,529.26
Jan 30, 2023	IDA-67950	Loan Disb	130,036.74
Dec 14, 2022	IDA-69230	Int Charges	29,354.99
Sep 15, 2022	IDA-67950	Int Charges	0.01
Sep 15, 2022	IDA-67950	Int Charges	592,343.94
Sep 15, 2022	IDA-67950	Int Charges	592,343.94
Sep 15, 2022	IDA-67950	Int Charges	607,424.60
Mar 28, 2023	IDA-67950	Int Charges	692,070.30
Mar 28, 2023	IDA-67950	Int Charges	3,430.08
Mar 28, 2023	IDA-67950	Int Charges	698,390.40
Mar 28, 2023	IDA-67950	Int Charges	698,390.40
Mar 28, 2023	IDA-66020	Int Charges	115,906.11
Mar 28, 2023	IDA-66020	Int Charges	115,906.11
Mar 28, 2023	IDA-66020	Int Charges	207,832.10
Aug 25, 2023	IDA-69230	Loan Disb	1,999,456.00
Aug 28, 2023	IDA-69230	Loan Disb	5,431,723.00
Nov 29, 2021	IDA-67950	Loan Disb	1,456,850.80
Sep 30, 2021	IDA-67950	Loan Disb	3,326,536.00
May 20, 2022	IDA-66020	Loan Disb	270,249.66
May 20, 2022	IDA-66020	Loan Disb	131,505.60
May 20, 2022	IDA-66020	Loan Disb	177,056.67
May 20, 2022	IDA-66020	Loan Disb	162,328.38
May 27, 2022	IDA-67950	Loan Disb	835,469.50
May 27, 2022	IDA-67950	Loan Disb	5,577,500.00
Mar 11, 2022	IDA-66020	Int Charges	120,320.93
Mar 11, 2022	IDA-66020	Int Charges	120,320.93
Mar 11, 2022	IDA-66020	Int Charges	208,866.56
Sep 15, 2021	IDA-69230	Loan Disb	6,552,207.00
Oct 14, 2021	IDA-69230	Loan Disb	4,946,265.00
Aug 17, 2021	IDA-67950	Int Charges	464,207.34
Aug 17, 2021	IDA-67950	Int Charges	464,207.34
Aug 17, 2021	IDA-67950	Int Charges	478,713.78
May 5, 2020	IDA-66020	Loan Disb	10,488,324.00
Sep 3, 2020	IDA-66020	Int Charges	19,493.55
Sep 3, 2020	IDA-66020	Int Charges	19,493.55
Sep 3, 2020	IDA-66020	Int Charges	30,925.09
Feb 16, 2021	IDA-67950	Loan Disb	8,637,603.00
Feb 16, 2021	IDA-67950	Loan Disb	64,300,000.00
Jun 1, 2022	IDA-69230	Int Charges	21,099.68
Jun 1, 2022	IDA-69230	Int Charges	25,805.38
Jun 1, 2022	IDA-69230	Int Charges	25,805.38
Jun 1, 2022	IDA-69230	Int Charges	461,314.56
Jun 1, 2022	IDA-69230	Int Charges	461,314.56
Jun 1, 2022	IDA-69230	Int Charges	347,837.50
May 23, 2022	IDA-66020	Loan Disb	103,689.98
Jul 12, 2022	IDA-67950	Loan Disb	681,610.10
Jul 12, 2022	IDA-67950	Loan Disb	200,905.38
Apr 14, 2022	IDA-67950	Loan Disb	2,095,750.00
Jun 15, 2022	IDA-69230	Loan Disb	59,012,928.00
Jun 15, 2022	IDA-66020	Loan Disb	658,522.30
Mar 18, 2022	IDA-67950	Loan Disb	6,394,637.50
May 5, 2022	IDA-67950	Loan Disb	589,196.44
Apr 20, 2022	IDA-67950	Loan Disb	331,497.10
May 20, 2022	IDA-66020	Loan Disb	114,527.26
May 20, 2022	IDA-66020	Loan Disb	122,542.05
Apr 8, 2022	IDA-67950	Loan Disb	3,956,598.80
Oct 23, 2020	IDA-66020	Loan Disb	23,371,940.00
Feb 10, 2021	IDA-66020	Int Charges	1,595.53
Feb 10, 2021	IDA-66020	Int Charges	90,095.49
Feb 10, 2021	IDA-66020	Int Charges	90,095.49
Feb 10, 2021	IDA-66020	Int Charges	147,950.50
Aug 6, 2021	IDA-66020	Int Charges	2,181.15
Aug 6, 2021	IDA-66020	Int Charges	129,033.55
Aug 6, 2021	IDA-66020	Int Charges	129,033.55
Aug 6, 2021	IDA-66020	Int Charges	215,055.88

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Project Management	Moderately Satisfactory	2024-11-20
Procurement	Satisfactory	2024-11-20
Financial Management	Moderately Satisfactory	2024-11-20
Progress towards achievement of PDO	Satisfactory	2024-11-20
Monitoring and Evaluation	Satisfactory	2024-11-20
Overall Implementation Progress (IP)	Moderately Satisfactory	2024-11-20

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Diagnosed cases treated in the designated treatment centers per approved protocol Value 0.00 100.00 80.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Diagnosed cases treated in the designated treatment centers per approved protocol (by % female) Value 0.00 100.00 80.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Designated acute healthcare facilities with isolation capacity Value 0.00 83.00 80.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Confirmed COVID-19 cases that conducted contact tracing Value 0.00 59.20 100.00
Date April 2, 2020 March 31, 2024 June 30, 2024
Comment
Infected health workers to COVID-19 treated Value 0.00 100.00 100.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Infected health workers to COVID-19 treated (by % female) Value 0.00 100.00 100.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment

Population vaccinated, who are included in the target population groups defined in the National COVID-19 Vaccine Deployment Plan	Value	0.00	57.10	41.60
	Date	March 1, 2021	March 31, 2024	December 31, 2024
	Comment

Proportion of females among those vaccinated Value 0.00 54.20 50.00
Date March 1, 2021 March 31, 2024 December 31, 2024
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Designated laboratories with COVID-19 diagnostic equipment, test kits and reagents Value 2.00 178.00 20.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Designated facilities for COVID-19 received monitoring and supportive supervision in preceding quarter Value 0.00 100.00 80.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
People having adequate knowledge on Infection Prevention and Control (IPC) measures Value 70.00 84.00 90.00
Date March 1, 2021 March 31, 2024 December 31, 2024
Comment
Quarterly reports with IDSR data submitted in a timely manner Value 0.00 95.60 90.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Designated laboratories diagnosed suspected COVID-19 cases within 24 hrs Value 2.00 178.00 20.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Designated highly fuel-efficient, low-carbon fuels or electric powered vehicles procured Value 0.00 19.00 12.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Complaints received and addressed within one week through the project GRM Value 0.00 100.00 100.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Women having adequate knowledge on Infection Prevention and Control (IPC) measures Value 0.00 86.00 90.00
Date March 1, 2021 March 31, 2024 December 31, 2024
Comment
Referral system to care for COVID-19 patients prepared Value No Yes Yes
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Treatment centers completed with ICU beds and providing services Value 0.00 28.00 19.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Cold chain system functional Value 62.70 81.00 100.00
Date March 1, 2021 March 31, 2023 December 31, 2024
Comment
All the regions have functional COVID-19 information centers (Number) Value 2.00 16.00 16.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
People who have received essential health, nutrition, and population (HNP) services Value 0.00 39764393.00 34800000.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
People are willing to take up COVID-19 vaccination Value 0.00 53.60 80.00
Date March 1, 2021 March 31, 2024 June 30, 2024
Comment
People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement) Value 0.00 8435632.00 11600000.00
Date
Comment
Women are willing to take up COVID-19 vaccination Value 0.00 59.00 80.00
Date March 1, 2021 March 31, 2024 December 31, 2024
Comment
Number of children immunized Value 0.00 8863458.00 2475000.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Number of women and children who have received basic nutrition services Value 0.00 13886927.00 2700000.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment
Number of deliveries attended by skilled health personnel Value 0.00 1023289.00 690000.00
Date April 2, 2020 March 31, 2024 December 31, 2024
Comment

Number of adolescents and children under 17 years of age vaccinated, which is included in the priority population targets defined in national plan	Value	0.00	443711.00	1090000.00
	Date	November 15, 2021	March 31, 2024	June 30, 2024
	Comment

Percentage of population receiving a booster, which is included in the population targets defined in the national plan Value 0.00 33.00 30.00
Date November 15, 2021 March 31, 2024 December 31, 2024
Comment

Designated laboratories with COVID-19 diagnostic equipment, test kits and reagents	Value	2.00	178.00	20.00
	Date	April 2, 2020	March 31, 2024	December 31, 2024
	Comment

People having adequate knowledge on Infection Prevention and Control (IPC) measures	Value	70.00	84.00	90.00
	Date	March 1, 2021	March 31, 2024	December 31, 2024
	Comment

Cold chain system functional	Value	62.70	81.00	100.00
	Date	March 1, 2021	March 31, 2023	December 31, 2024
	Comment

Number of children immunized	Value	0.00	8863458.00	2475000.00
	Date	April 2, 2020	March 31, 2024	December 31, 2024
	Comment

People who have received essential health, nutrition, and population (HNP) services - Female (RMS requirement)	Value	0.00	8435632.00	11600000.00
	Date
	Comment

Ghana COVID-19 Emergency Preparedness and Response Project

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS